Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 234937, 6 pages
http://dx.doi.org/10.1155/2012/234937
Research Article

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects

1Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Department of Biochemistry, Faculty of Medicine, Sana’a, Yemen
3Department of Medicine, University Malaya Medical Centre, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Faculty of Dentistry, Ibb University, Ibb, Yemen

Received 16 October 2011; Revised 5 February 2012; Accepted 15 February 2012

Academic Editor: Leonid Medved

Copyright Β© 2012 Zaid Al-Hamodi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Jerzy Jankun, Victor Kondray, and Ewa Skrzypczak-Jankun, “Analysis of the inhibition of PAI-1 by metal theaflavin complexes and their degradation products,” International Journal of Molecular Medicine, vol. 31, no. 5, pp. 1153–1158, 2013. View at Publisher Β· View at Google Scholar
  • E. Valle-Garay, A. H. Montes, J. R. Corte, A. Meana, J. Fierer, and V. Asensi, “tPA Alu (I/D) Polymorphism Associates With Bacterial Osteomyelitis,” Journal of Infectious Diseases, vol. 208, no. 2, pp. 218–223, 2013. View at Publisher Β· View at Google Scholar
  • Kuanfeng Xu, Xiaoyun Liu, Fan Yang, Dai Cui, Yun Shi, Chong Shen, Wei Tang, and Tao Yang, “PAI-1-675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study,” Plos One, vol. 8, no. 11, 2013. View at Publisher Β· View at Google Scholar
  • Harry Robberecht, and Nina Hermans, “Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance,” Metabolic Syndrome and Related Disorders, 2016. View at Publisher Β· View at Google Scholar